Rain Oncology Inc. Annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from 2020 to 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
-
Summary
-
Rain Oncology Inc. quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from 2020 to 2022.
- Rain Oncology Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending September 30, 2023 was -$7M, a 61.1% increase year-over-year.
- Rain Oncology Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending September 30, 2023 was -$72M, a 0.96% decline year-over-year.
- Rain Oncology Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2022 was -$75.8M, a 47.2% decline from 2021.
- Rain Oncology Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was -$51.5M, a 144% decline from 2020.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Annual (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Annual Growth (%)